Research location

Tbilisi

Georgia

Published trials292

Site observations1,075

Linked trials published292

Page1 / 6

Research activity in Tbilisi

Georgia

CureCurrent currently publishes aggregate city-level research activity for this location: 292 trials and 1,075 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Tbilisi

292 linked trials · page 1 of 6

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaNCT07476326 · 2026-09-09 · 5 site observations

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)NCT07625644 · 2026-08-04 · 6 site observations

Synchronized Diaphragmatic Stimulation in Symptomatic Heart FailureNCT06552637 · 2026-07-08 · 1 site observation

A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid ArthritisNCT07433335 · 2026-04-07 · 1 site observation

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)NCT07503873 · 2026-04-01 · 4 site observations

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous DurvalumabNCT07391670 · 2026-03-31 · 2 site observations

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019 · 2026-03-23 · 2 site observations

A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463 · 2026-03-23 · 3 site observations

REGN7508 in Adult Participants for Prevention of Cancer-Associated ThrombosisNCT07410117 · 2026-03-09 · 7 site observations

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)NCT07363590 · 2026-02-19 · 1 site observation

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)NCT07359846 · 2026-01-20 · 4 site observations

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT07179380 · 2026-01-07 · 4 site observations

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)NCT06996782 · 2025-11-24 · 4 site observations

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNCT07472517 · 2025-11-07 · 1 site observation

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockNCT07293923 · 2025-11-05 · 2 site observations

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerNCT07173751 · 2025-10-30 · 3 site observations

A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid ArthritisNCT07230353 · 2025-10-21 · 1 site observation

Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI ProcedureNCT07407816 · 2025-10-12 · 1 site observation

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid ArthritisNCT07207954 · 2025-10-06 · 1 site observation

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeNCT07190209 · 2025-09-16 · 5 site observations

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)NCT06944925 · 2025-05-08 · 4 site observations

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerNCT06827236 · 2025-04-23 · 1 site observation

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerNCT06868277 · 2025-04-10 · 4 site observations

Alleviant ALLAY-HFrEF StudyNCT06812533 · 2025-03-10 · 1 site observation

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerNCT06712316 · 2025-01-07 · 4 site observations

A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.NCT06701721 · 2024-12-20 · 3 site observations

A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusNCT06700538 · 2024-12-04 · 4 site observations

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) ShuntNCT06691555 · 2024-11-08 · 1 site observation

PRIDE III Prison Interventions and HIV Prevention CollaborationNCT06962033 · 2024-11-05 · 1 site observation

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 5 site observations

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesNCT06395129 · 2024-09-13 · 1 site observation

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious InfectionsNCT06056297 · 2024-06-06 · 4 site observations

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)NCT06345729 · 2024-05-24 · 6 site observations

Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral RegurgitationNCT06414265 · 2024-04-04 · 2 site observations

Reprieve System Pilot StudyNCT06272734 · 2024-01-23 · 1 site observation

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583 · 2023-11-15 · 4 site observations

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyNCT05774951 · 2023-03-31 · 4 site observations

Alleviant ALLAY-HF StudyNCT05685303 · 2023-01-10 · 1 site observation

First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for CancerNCT05460780 · 2022-07-01 · 1 site observation

Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its ComorbiditiesNCT05369065 · 2022-01-27 · 3 site observations

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersNCT05098132 · 2022-01-25 · 3 site observations

ContraBand™: Safety & Feasibility Study (RM-20-01)NCT05230745 · 2021-09-28 · 1 site observation

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEFNCT04592445 · 2020-12-18 · 2 site observations

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 5 site observations

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic DiseasesNCT03549754 · 2018-02-17 · 1 site observation

Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHFNCT07810335 · 2026-09-05 · 2 site observations

NOT_YET_RECRUITING

Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung CancerNCT07627022 · 2026-07-01 · 1 site observation

NOT_YET_RECRUITING

Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection FractionNCT07598760 · 2026-05-30 · 2 site observations

NOT_YET_RECRUITING

Physical Activity During Radiation Therapy for Lung CancerNCT07380815 · 2026-02-01 · 1 site observation

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid TumorsNCT07160335 · 2025-09-26 · 5 site observations

ACTIVE_NOT_RECRUITING

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.